PROGRESS MONITOR 2017

(1)

NONCOMMUNICABLE DISEASES

PROGRESS MONITOR 2017

(2)

NONCOMMUNICABLE DISEASES

PROGRESS MONITOR 2017

(3)

Noncommunicable Diseases Progress Monitor, 2017 ISBN 978-92-4-151302-9

Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial- ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc- sa/3.0/igo).

Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”.

Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.

Suggested citation. Noncommunicable Diseases Progress Monitor, 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO.

Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris.

Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing.

Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party- owned component in the work rests solely with the user.

General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

All reasonable precautions have been taken by WHO to verify the information contained in this publication.

However, the published material is being distributed without warranty of any kind, either expressed or implied.

The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO be

(4)

ACKNOWLEDGEMENTS

This report was prepared by Leanne Riley, Hebe Gouda and Melanie Cowan from the Surveillance and Population-Based Prevention Unit, Department for Prevention of Noncommunicable Diseases, World Health Organization (WHO).

Contributions to the report were made by the following colleagues in WHO Headquarters and Regional Offices: Naveen Agarwal, Douglas Bettcher, Lubna Bhatti, Fiona Bull, Roberta Caixeta, Marie Clem Carlos, Alison Commar, Carolina Chavez Cortez, Kaia Engesveen, Heba Fouad, Alexandra Fleischmann, Larry Grummer-Strawn, Regina Guthold, Warrick Junsuk Kim, Anna Kurmanova, Enrique Loyola Elizondo, Doris Ma Fat, Colin Mathers, Jayasuriya Navaratne, Leo Nederveen, Nivo Ramanandraibe, Manju Rani, Dag Rekve, Stefan Savin, Kerstin Schotte, Bela Shah, Kate Sheffer, Hai-Rim Shin, Wendy Snowdon, Chandralall Sookram, Gretchen Stevens, Menno Van Hilten, Cherian Varghese, and Temo Waquanivalu.

Sincere thanks to all WHO Member States for their assistance in reporting data to

WHO which allowed compilation of these indicators.

(6)

FOREWORD

Premature death from noncommunicable diseases (NCDs) continues to be one of the major development challenges in the 21st century. NCDs kill 15 million women and men between the ages of 30 and 70 each year, and leave no country untouched.

This burden is rising disproportionately among low-income and lower-middle-income countries, where almost half of premature NCD deaths occur. Within countries, these deaths disproportionally affect the poorest and those furthest behind. The NCD epidemic is driven by poverty, globalization of marketing and trade of health-harming products, rapid urbanization, and population growth.

This Progress Monitor is based on the latest data tracked against 10 progress indicators to chart progress in developing national responses. It describes achievements and challenges faced by all countries in fulfilling promises made since the first United Nations High-level Meeting on NCDs in 2011.

Most premature NCD deaths can be prevented or delayed by implementing a set of so called “best buys” and other interventions to prevent and control these conditions, primarily cardiovascular and chronic respiratory diseases, cancer and diabetes. These measures were endorsed by the 70th World Health Assembly and are available to all countries.

World leaders committed in the Agenda for Sustainable Development to reduce premature NCD deaths by one third by 2030 and promote mental health and wellbeing (Sustainable Development Goal target 3.4).

Since the 2011 High-level Meeting, governments have made many political commitments to prevent and control NCDs. Progress, however, has been insufficient and highly uneven. Unless political leaders accelerate commitments to take national action at the third UN High-level Meeting in 2018, the current rate of decline in premature death from NCDs will not meet the SDG target, leading to significant GDP losses and impoverishing millions of people through long-term healthcare costs.

To promote accountability to the world’s citizens, WHO defined the 10 national progress

indicators that it will use to develop a report in November 2017 for the UN General

Assembly. Member States will review this report in January 2018, which will set the tone

for negotiations on the outcome document for the third High-level Meeting.

(7)

This report shows we are on the path to tangible progress in countries, and that the roadmap contained in the 2011 Political Declaration can promote collective action for faster results. However, it also reveals progress has been impeded in many countries and that bolder political action is needed to address constraints, including the mobilization of domestic and external resources and safeguarding communities from interference by powerful economic operators.

This Progress Monitor urges Member States to ensure that the steps needed for all people, especially the poorest, to live in a world free of the avoidable burden of NCDs are reiterated at the 2018 High-level Meeting.

The UN, as a global beacon of solidarity, must also show it can shape such a world. In so doing, it must keep listening to and involving the peoples of the world. It must build a future that ensures globalization becomes a positive force for present and future generations.

Dr Tedros Adhanom Ghebreyesus Director-General

World Health Organization

(8)

INTRODUCTION

Noncommunicable diseases (NCDs), such as cardiovascular diseases, cancer, diabetes and chronic respiratory diseases, are the leading global cause of death and are responsible for 70% of deaths worldwide. These NCDs share key modifiable behavioural risk factors like tobacco use, unhealthy diet, lack of physical activity, and the harmful use of alcohol, which in turn lead to overweight and obesity, raised blood pressure, and raised cholesterol, and ultimately disease. They continue to be an important public health challenge in all countries, including low- and middle-income countries where more than three quarters of NCD deaths occur.

Effectively tackling NCDs and their key risk factors requires a detailed understanding of the current status and progress being made at the country level. Feasible and cost- effective interventions exist to reduce the burden and impact of NCDs now and in the future. Tracking national implementation of a key set of tracer actions linked to these interventions allows for global benchmarking and monitoring of progress being made against NCDs. It also serves to highlight challenges and areas requiring further attention.

In May 2015 the World Health Organization published a Technical Note (1) on how

WHO will report in 2017 to the United Nations General Assembly on the progress

achieved in the implementation of national commitments included in the 2011 UN

Political Declaration and the 2014 UN Outcome Document on NCDs. The Technical

Note was updated in September 2017 to ensure consistency with the revised set of

WHO ‘best-buys’ and other recommended interventions for the prevention and control

of noncommunicable diseases which were endorsed by the World Health Assembly

in May 2017. The Technical Note outlines a set of ten progress monitoring indicators

intended to show the progress achieved in countries in the implementation of selected

national commitments included in the 2014 Outcome Document. The ten NCD progress

monitoring indicators are as follows:

(9)

Consider setting national NCD targets for 2025:

Reduce risk factors for NCDs, building on guidance set out in the WHO Global NCD Action Plan:

Consider developing national multisectoral policies and plans to achieve the national targets by 2025:

Member State has set time-bound national targets based on WHO guidance

Member State has implemented the following five demand-reduction measures of the WHO FCTC at the highest level of achievement:

Member State has a functioning system for generating reliable cause-specific mortality data on a routine basis

Member State has a STEPS survey or a comprehensive health examination survey every 5 years

Member State has an operational multisectoral national strategy/

action plan that integrates the major NCDs and their shared risk factors

1 1 1

1 1

5 1 1 2 1 1 3

4

a b c d

Reduce affordability by increasing excise taxes and prices on tobacco products

Eliminate exposure to second-hand tobacco smoke in all indoor workplaces, public places and public transport

Implement plain/standardized packaging and/or large graphic health warnings on all tobacco packages

Enact and enforce comprehensive bans on tobacco advertising, promotion and sponsorship

(10)

Member State has implemented, as appropriate according to national circumstances, the following three measures to reduce the harmful use of alcohol as per the WHO Global Strategy to Reduce the Harmful Use of Alcohol:

Member State has implemented the following four measures to reduce unhealthy diets:

Member State has implemented at least one recent national public awareness and motivational communication for physical activity, including mass media campaigns for physical activity behavioural change.

1

1 1 1

1 1 6

7

8 9 10

a b c d

Enact and enforce restrictions on the physical availability of retailed alcohol (via reduced hours of sale)

Adopt national policies to reduce population salt/sodium consumption

Adopt national policies that limit saturated fatty acids and virtually eliminate industrially produced trans fatty acids in the food supply

WHO set of recommendations on marketing of foods and non-alcoholic beverages to children

Legislation /regulations fully implementing the International Code of Marketing of Breast-milk Substitutes

Enact and enforce bans or comprehensive restrictions on exposure to alcohol advertising (across multiple types of media)

Increase excise taxes on alcoholic beverages a

b c

Member State has evidence-based national guidelines/protocols/

standards for the management of major NCDs through a primary care approach, recognized/approved by government or competent authorities

Strengthen health systems to address NCDs through people-centred primary health care and universal health coverage, building on guidance set out in WHO Global NCD Action Plan:

(11)

EXPLANATORY NOTES

This report presents information for each country related to their achievement of the NCD progress monitoring indicators. The profiles also include information on the population, percentage and number of deaths from NCDs, and the risk of premature death from the four main NCDs (cardiovascular diseases, cancer, diabetes or chronic respiratory diseases) – the indicator used to monitor the Sustainable Development Goal target 3.4 on NCDs. The data presented in the country pages are derived from several sources, each of which is explained in the following notes.

Progress monitoring indicators

Details of the progress monitoring indicators, including detailed definitions, specifications, data sources and assessment criteria are included in Appendix 1.

For each indicator the following symbols denote the level of achievement: = fully achieved, = partially achieved, = not achieved, “NA” = not applicable to country due to national situation, “DK” = country responded “don’t know” to that question in the survey, and “NR” = no response or missing data.

Assessment of indicators 1, 3, 4, 7a, 7b, 7c, 8, 9 and 10 were taken from Member State responses to the 2017 NCD Country Capacity Survey (NCD CCS). The 2017 NCD CCS questionnaire was completed through an online web-based platform by the NCD focal points or designated colleagues within the Ministry of Health (MOH) or a national institute or agency in all WHO Member States (194 countries) between February and June 2017. The questions were developed in a manner intended to obtain objective information about adequacy of capacity and countries were required to provide supporting documentation to enable review by WHO in order to validate the responses. Where discrepancies were noted between the country response and the documents provided for validation, a clarification request was returned to the country for their consideration and an updating of their response.

Assessment of indicators 7a, 7b and 7c were additionally reviewed against responses obtained by WHO in the 2nd Global Nutrition Policy Review and supporting documentation contained in the WHO Global database on the Implementation of Nutrition Action (GINA).

Assessment of indicator 2 related to the system for generating mortality data was

based on data collected by WHO and stored in the WHO mortality database through

(12)

Assessment of indicator 5 was based on data collected from Member States in 2016 for the production of the WHO Report on the Global Tobacco Epidemic. The WHO assessment was shared with national authorities for review and approval.

Indicator 6 achievement status was based on the responses of country focal points, officially nominated by the Ministry of Health, to the 2016 Global Survey on Alcohol and Health conducted by WHO. Responses were reviewed and validated by WHO, and subsequently endorsed by the Member States.

Indicator 7d achievement status was based on the analysis by WHO, UNICEF, and IBFAN/ICDC of copies of all national legislation and regulations on the International Code of Marketing of Breast-milk Substitutes for the production of the report on Marketing of breast-milk substitutes: National implementation of the international code Status Report 2016.

Demographics

The 2015 population estimates from the most recent United Nations Population Division World Population Prospects (2) are reported in each profile.

Mortality

Percentage of deaths from NCDs and total number of NCD deaths are reported for 2015 for all countries with a population greater than 90,000. These data were drawn from the 2015 all-cause mortality rates estimated from revised life tables, published in World Health Statistics 2017 (3). Total number of deaths by age and sex were estimated for each country by applying these death rates to the estimated resident populations prepared by the United Nations Population Division in its 2015 revision (2). Vital registration systems which record deaths with sufficient completeness and quality of cause of death information were used as the preferred data source. Detailed information on methods for mortality and causes of death estimates were published previously (4).

The risk of premature death from target NCDs presented in the profiles is the probability

of dying between ages 30 and 70 years from the four main NCDs and was estimated

for 2015 using age-specific death rates (in 5-year age groups, e.g. 30-34… 65-69,

for those between 30 and 70) of the combined four main NCD categories, for each

Member State (4). Using the life table method, the risk of death between the exact ages

of 30 and 70, from any of the four causes and in the absence of other causes of death,

(13)

was calculated using the equation below. The ICD codes used are: Cardiovascular disease: I00-I99, ‪Cancer: C00-C97, Diabetes: E10-E14, ‪and Chronic respiratory disease: J30-J98.‪‪

Five-year death rates were then translated into the probability of death for each NCD using the following formula:

The unconditional probability of death, for the 30-70 age range, was calculated last:

(14)

REFERENCES

1. http://www.who.int/nmh/events/2015/technical-note-en.pdf?ua=1, accessed 4 September 2017.

2. World Population Prospects: The 2017 Revision, Key Findings and Advance Tables. New York, United Nations Population Division, 2017.

3. World Health Statistics 2017: monitoring health for the SDGs, Sustainable Development Goals. Geneva, World Health Organization, 2017.

4. WHO methods and data sources for country-level causes of death 2000-2015.

Geneva, World Health Organization, 2017.

(15)

(16)

COUNTRY

PROFILES

(17)

33 736 000 42% 110 000 31%

Total population Percentage of deaths

from NCDs Total number of NCD

deaths Risk of premature death from target NCDs

National NCD targets

○

Mortality data

○

Risk factor surveys ◐

National integrated NCD policy/strategy/action plan

●

Tobacco demand-reduction measures:

increased excise taxes and prices

○

smoke-free policies

●

large graphic health warnings/plain packaging ◐

bans on advertising, promotion and sponsorship

●

mass media campaigns

○

Harmful use of alcohol reduction measures:

restrictions on physical availability

●

advertising bans or comprehensive restrictions

●

increased excise taxes

●

Unhealthy diet reduction measures:

salt/sodium policies ◐

saturated fatty acids and trans-fats policies

●

marketing to children restrictions

●

marketing of breast-milk substitutes restrictions

●

Public education and awareness campaign on physical activity DK Guidelines for management of cancer, CVD, diabetes and CRD

○

Drug therapy/counselling to prevent heart attacks and strokes

○

● = fully achieved ◐ = partially achieved ○ = not achieved DK = don't know

AFGHANISTAN

(18)

2 923 000 92% 20 000 15%

National NCD targets ◐

Mortality data ◐

●

increased excise taxes and prices ◐

smoke-free policies

●

mass media campaigns ◐

restrictions on physical availability ◐

○

increased excise taxes ◐

salt/sodium policies

○

●

Public education and awareness campaign on physical activity

○

Guidelines for management of cancer, CVD, diabetes and CRD ◐ Drug therapy/counselling to prevent heart attacks and strokes ◐

● = fully achieved ◐ = partially achieved ○ = not achieved

ALBANIA

(19)

39 872 000 74% 144 000 15%

●

Mortality data

○

National integrated NCD policy/strategy/action plan ◐ Tobacco demand-reduction measures:

○

smoke-free policies ◐

large graphic health warnings/plain packaging

○

bans on advertising, promotion and sponsorship ◐

mass media campaigns NR

●

○

marketing of breast-milk substitutes restrictions ◐

●

Guidelines for management of cancer, CVD, diabetes and CRD ◐ Drug therapy/counselling to prevent heart attacks and strokes DK

● = fully achieved ◐ = partially achieved ○ = not achieved DK = don't know NR = No Response

ALGERIA

(20)

78 000 - - -

from NCDs† Total number of NCD

deaths† Risk of premature death from target NCDs†

○

Mortality data ◐

○

marketing of breast-milk substitutes restrictions NR

●

Guidelines for management of cancer, CVD, diabetes and CRD

○

Drug therapy/counselling to prevent heart attacks and strokes DK

● = fully achieved ◐ = partially achieved ○ = not achieved DK = don't know NR = No Response † = see Explanatory Notes

ANDORRA

(21)

27 859 000 27% 93 000 25%

○

Mortality data

○

increased excise taxes and prices NR

○

Public education and awareness campaign on physical activity NR Guidelines for management of cancer, CVD, diabetes and CRD DK Drug therapy/counselling to prevent heart attacks and strokes

○

◐ = partially achieved ○ = not achieved DK = don't know NR = No Response

ANGOLA

(22)

100 000 80% 400 16%

○

Mortality data

●

Risk factor surveys

○

●

○

smoke-free policies

○

●

○

ANTIGUA AND BARBUDA

(23)

43 418 000 81% 268 000 17%

●

Mortality data

●

smoke-free policies

●

○

advertising bans or comprehensive restrictions ◐

●

○

ARGENTINA

(24)

2 917 000 93% 27 000 23%

●

Mortality data

●

Risk factor surveys

●

○

●

○

●

○

●

○

● = fully achieved ◐ = partially achieved ○ = not achieved NR = No Response

ARMENIA

(25)

23 800 000 90% 136 000 9%

Mortality data

●

smoke-free policies

●

○

●

○

●

Drug therapy/counselling to prevent heart attacks and strokes DK

AUSTRALIA

(26)

8 679 000 92% 72 000 11%

○

Mortality data

●

○

●

smoke-free policies

○

●

○

●

○

●

○

●

AUSTRIA

(27)

9 617 000 86% 57 000 24%

●

Mortality data ◐

Risk factor surveys

●

○

●

Guidelines for management of cancer, CVD, diabetes and CRD ◐ Drug therapy/counselling to prevent heart attacks and strokes

○

AZERBAIJAN

(28)

387 000 74% 1 000 17%

●

Mortality data

●

○

smoke-free policies

○

●

○

saturated fatty acids and trans-fats policies DK

○

●

Guidelines for management of cancer, CVD, diabetes and CRD ◐ Drug therapy/counselling to prevent heart attacks and strokes DK

BAHAMAS

(29)

1 372 000 85% 2 000 16%

●

Mortality data ◐

○

smoke-free policies

○

●

restrictions on physical availability NR

advertising bans or comprehensive restrictions NR

increased excise taxes NR

●

Guidelines for management of cancer, CVD, diabetes and CRD DK Drug therapy/counselling to prevent heart attacks and strokes

●

BAHRAIN

(30)

161 000 000 67% 580 000 22%

Mortality data

○

●

○

marketing to children restrictions DK

○

●

○

BANGLADESH

(31)

284 000 83% 2 000 16%

●

Mortality data ◐

●

○

smoke-free policies

●

○

●

○

BARBADOS

(32)

9 486 000 89% 114 000 29%

Mortality data

●

Risk factor surveys

●

○

smoke-free policies

○

●

○

●

BELARUS

(33)

11 288 000 86% 94 000 12%

○

Mortality data

●

○

●

○

●

○

●

BELGIUM

(34)

359 000 66% 1 000 22%

●

Mortality data

●

○

smoke-free policies

○

●

○

BELIZE

(35)

10 576 000 37% 36 000 22%

○

Mortality data

○

●

○

●

○

●

○

BENIN

(36)

787 000 68% 3 000 23%

●

Mortality data

○

●

increased excise taxes and prices NA

○

●

○

●

○

● = fully achieved ◐ = partially achieved ○ = not achieved NA = not applicable

BHUTAN

(37)

10 725 000 62% 44 000 16%

Mortality data ◐

Risk factor surveys

○

●

○

restrictions on physical availability NR

advertising bans or comprehensive restrictions NR

increased excise taxes NR

○

●

○

○ BOLIVIA (PLURINATIONAL STATE OF)

(38)

3 536 000 94% 37 000 18%

National NCD targets DK

Mortality data ◐

●

smoke-free policies

○

●

salt/sodium policies DK

○

●

● BOSNIA AND HERZEGOVINA

(39)

2 209 000 42% 6 000 19%

○

Mortality data

○

Risk factor surveys

●

○

smoke-free policies

○

●

○

●

○

●

○

BOTSWANA

(40)

206 000 000 73% 928 000 17%

●

Mortality data

●

Risk factor surveys

●

smoke-free policies

●

○

●

○

BRAZIL

(41)

418 000 80% 1 000 13%

●

Mortality data

●

Risk factor surveys

●

increased excise taxes and prices NA

smoke-free policies

●

○

●

salt/sodium policies DK

○

●

● = fully achieved ◐ = partially achieved ○ = not achieved DK = don't know NA = not applicable

BRUNEI DARUSSALAM

(42)

7 177 000 95% 101 000 24%

●

Mortality data

●

smoke-free policies

●

○

●

○

●

BULGARIA

(43)

18 111 000 33% 51 000 23%

●

Mortality data

○

●

○

smoke-free policies

●

○

BURKINA FASO

(44)

10 199 000 31% 32 000 22%

●

Mortality data

○

Risk factor surveys

○

smoke-free policies

○

BURUNDI

(45)

533 000 68% 1 000 16%

Mortality data ◐

●

○

smoke-free policies

○

●

○

●

CABO VERDE

(46)

15 518 000 61% 57 000 23%

Mortality data

○

Risk factor surveys

●

○

smoke-free policies

●

○

CAMBODIA

(47)

22 835 000 34% 83 000 22%

●

Mortality data

○

●

○

●

○

CAMEROON

PROGRESS MONITOR 2017

NONCOMMUNICABLE DISEASES